1445A SOUTH 50TH STREET, RICHMOND, CA
Other Events
Reports Second Quarter 2026 Financial Results and Provides Business Updates
Stockholders Approve Election of Directors at BioAge Labs Annual Meeting
Reports First Quarter 2026 Financial Results and Provides Business Updates
Annual Report to Security Holders
Earnings Release
Announces Pricing of Upsized $115.0 Million Public Offering
BioAge to Expand BGE-102 Use, Starts Diabetic Macular Edema Trial in 2026
Q2
Q1
FY 2025
Q3
FY 2024
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
S-1MEF